Zai Lab Limited (ZLAB)
NASDAQ: ZLAB · Real-Time Price · USD
30.14
-1.17 (-3.74%)
At close: May 30, 2025, 4:00 PM
30.16
+0.02 (0.07%)
After-hours: May 30, 2025, 6:52 PM EDT
Zai Lab Employees
Zai Lab had 1,869 employees as of December 31, 2024. The number of employees decreased by 306 or -14.07% compared to the previous year.
Employees
1,869
Change (1Y)
-306
Growth (1Y)
-14.07%
Revenue / Employee
$223,823
Profits / Employee
-$134,869
Market Cap
3.27B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
ZLAB News
- 11 hours ago - Zai Lab Announces Participation in Investor Conferences in June 2025 - Business Wire
- 2 days ago - Zai Lab Limited Is Well Positioned For Long-Term Growth - Seeking Alpha
- 8 days ago - Zai Lab Limited: Banking On Chinese Pharma Growth - Seeking Alpha
- 11 days ago - Zai Lab Receives U.S. FDA Fast Track Designation for ZL-1310, a DLL3-Targeted Antibody-Drug Conjugate, for Treatment of Extensive-Stage Small Cell Lung Cancer - Business Wire
- 19 days ago - Zai Lab Limited (ZLAB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 22 days ago - Zai Lab Announces First Quarter 2025 Financial Results and Recent Corporate Updates - Business Wire
- 5 weeks ago - Zai Lab Presents Data Highlighting Potential of Internally Developed, Next-Generation Oncology Therapies at AACR 2025 - Business Wire
- 5 weeks ago - Zai Lab to Present Data from Phase 1 Trial of DLL3-Targeted Antibody-Drug Conjugate (ADC) ZL-1310 at 2025 ASCO Annual Meeting - Business Wire